Panakès Partners
Venture capital
UncertainLast verified 12 Nov 2026
Italian venture capital firm investing globally in life sciences startups and SMEs focused on medical technologies and biotech therapies to address unmet medical needs.
2 deals in the last 24 months, latest 6 Oct 2025. Derived from its deals in the news.
Key facts
- Stages
- Series A, Series C+
- Sectors
- Biotech & pharma, Medtech, Healthtech
- Eligible countries
- Not stated
- Provider based in
- Italy
- Timing
- Rolling applications
- Focus
- Life Sciences; Biotech therapies; Medical technologies; Unmet medical needs
- How to apply
- Apply route unknown
- Source
- https://www.panakes.it/
Recent deals
| Company | Round | Sectors | Amount | Role | Announced |
|---|---|---|---|---|---|
| NanoPhoria Bioscience | Series A | Biotech & pharma, Healthtech | €83.5M | participant | 6 Oct 2025 |
| DeepUll · Spain | Series C+ | Healthtech, Medtech, Biotech & pharma | – | lead | 29 Apr 2025 |
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
Panakès Partners is a venture capital firm backing ambitious start-ups and entrepreneurs with innovative products in Life Sciences.
https://www.panakes.it/ - Sectors
Identify Biotech Therapies and Medical Technologies to satisfy Highly Unmet Medical Needs.
https://www.panakes.it/
Status history
- 12 Nov 2026: Rolling → Uncertain (freshness: investor activity)
- 6 Nov 2026: Rolling (first extraction)
Is something out of date?
Suggest an editTakes 10 seconds
Something else wrong? Report an error.
Work at Panakès Partners? Claim this profile to confirm what you invest in.